Angiotensin Converting Enzyme Inhibitor-Related Angioedema
- 24 July 2014
- journal article
- research article
- Published by SAGE Publications in Annals of Otology, Rhinology & Laryngology
- Vol. 124 (2), 89-96
- https://doi.org/10.1177/0003489414543069
Abstract
Objective: : This study aimed to determine the duration of use, presentation, and management of angiotensin converting enzyme (ACE) inhibitor-related angioedema patients at an urban academic medical center. Methods: : Retrospective chart review. Results: : Eighty-eight patients who presented with ACE inhibitor-related angioedema between January 1, 2012, and December 31, 2012, were identified. They presented anywhere from 1 day to 20 years after starting an ACE inhibitor. About half the patients (50.7%) presented after taking an ACE inhibitor for at least 1 year. Fifty-five patients were female (62.5%). Twenty-eight patients (31.8%) had an airway intervention with 27 intubated and 1 requiring cricothyroidotomy. Six patients were intubated after more than 1 flexible laryngoscopy. The percentage of patients with involvement of the face, lips, tongue, floor of mouth, soft palate/uvula, and larynx were 12.5%, 60.2%, 39.7%, 6.8%, 17.0%, and 29.5%, respectively. Sixty-eight percent of patients with laryngeal edema were intubated. The majority of patients were treated with a corticosteroid and H1 and H2 receptor antagonists. Conclusion: : Angioedema can occur at any time after starting ACE inhibitor use, with nearly half occurring after 1 year of use. Laryngeal involvement occurred in a minority of patients, but most of these patients were felt to require airway protection.Keywords
This publication has 25 references indexed in Scilit:
- Emergency Department Management of Patients with ACE-inhibitor AngioedemaThe Journal of Emergency Medicine, 2013
- Chronic Cough: An UpdateMayo Clinic Proceedings, 2013
- Genetic variants associated with angiotensin-converting enzyme inhibitor-associated angioedemaPharmacogenetics and Genomics, 2013
- Management of angiotensin‐converting enzyme inhibitor–induced angioedemaThe Laryngoscope, 2011
- Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedemaPharmacogenetics and Genomics, 2010
- Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme InhibitorsHypertension, 2008
- Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency departmentAnnals of Allergy, Asthma & Immunology, 2008
- Clinical experience with angiotensin‐converting enzyme inhibitor–induced angioedemaOtolaryngology -- Head and Neck Surgery, 2007
- Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)The Journal of Clinical Hypertension, 2006
- Incidence and Characteristics of Angioedema Associated With EnalaprilArchives of Internal Medicine, 2005